I'm not sure how many times it has been explained to you... If you conduct a trial with Aus participation you can leverage greater rebates from overseas trial sites.
If there's no Aus trial sites, there's limited/no rebate... IMU got complacent with trial design when they pulled in the Covid money and hence why they ploughed ahead with onCARlytics stateside only...
They've learnt this lesson the hard way, this is why they brought Azercel to Aus in 2025... this also means the rebate from FY25 will be minimal...
What is it you don't understand!?
#DEATHSPIRAL
IMU Price at posting:
1.3¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)